Global Menopause Drug Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. (Mar) Menopause Drug is a type of walk-in clinic that provides ambulatory care in a dedicated medical facility outside of a conventional emergency room (ER). Also, the Menopause Drug is used for treating injuries and illness that need immediate care. The increase in percentage of women aged 40-65 years impacted them the most has led the adoption of Menopause Drug across the forecast period. According to a survey conducted in 2021 by Statista, 1 in 6 women aged 40 to 65 claimed hot flashes were the most bothersome symptom of menopause. Another 15% experienced weight increase, with vaginal dryness and uncomfortable sex affecting the majority of women (12%). As of 2021, this statistic shows the percentage of women aged 40 to 65 in the United States who reported that menopause symptoms affected them the most. Also, with the increasing research and development in the drugs, the adoption & demand for Menopause Drug is likely to increase the market growth during the forecast period. However, low awareness regarding this drug impedes the growth of the market over the forecast period of 2022-2028.
The key regions considered for the global Menopause Drug Market study includes Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the significant region across the world in terms of market share owing to the high prevalence of unhealthy lifestyle and rising introduction of novel drugs in this region. Whereas, Asia-Pacific is anticipated to exhibit highest CAGR over the forecast period 2022-2028. Factors such as increase in the vulnerable aging population of menopause women and increase in the demand of novel therapies would create lucrative growth prospects for the Menopause Drug Market across Asia-Pacific region.
Major market player included in this report are:
Teva Pharmaceutical Industries Ltd.
Eli Lilly and Company
Cipla Inc
Allergan
Pfizer, Inc
Novo Nordisk A/S
Novartis AG
Merck & Co., Inc
Emcure
Viramal,
EuroPharma USA
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Stages Type:
Perimenopause
Menopause
Post menopause
By Treatment Type:
Non-Hormonal Treatment
Hormonal Treatment
Herbal Supplements
By Product Type:
Patch
Pill
Gel
Injectable
Cream
Others
By Route of Administration Type:
Oral
Injectable
Topical
By End Users:
Hospitals
Homecare
Specialty Clinics
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019, 2020
Base year - 2021
Forecast period - 2022 to 2028
Target Audience of the Global Menopause Drug Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Table of Contents
Chapter 1. Executive Summary
- 1.1. Market Snapshot
- 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
- 1.2.1. Menopause Drug Market, by Region, 2020-2028 (USD Billion)
- 1.2.2. Menopause Drug Market, by Stages Type, 2020-2028 (USD Billion)
- 1.2.3. Menopause Drug Market, by Treatment Type, 2020-2028 (USD Billion)
- 1.2.4. Menopause Drug Market, by Product Type, 2020-2028 (USD Billion)
- 1.2.5. Menopause Drug Market, by Route of Administration Type, 2020-2028 (USD Billion)
- 1.2.6. Menopause Drug Market, by End Users, 2020-2028 (USD Billion)
- 1.3. Key Trends
- 1.4. Estimation Methodology
- 1.5. Research Assumption
Chapter 2. Global Menopause Drug Market Definition and Scope
- 2.1. Objective of the Study
- 2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
- 2.3. Years Considered for the Study
- 2.4. Currency Conversion Rates
Chapter 3. Global Menopause Drug Market Dynamics
- 3.1. Menopause Drug Market Impact Analysis (2020-2028)
- 3.1.1. Market Drivers
- 3.1.1.1. Increasing percentage of women aged 40-65 years who are suffering from menopause
- 3.1.2. Market Challenges
- 3.1.2.1. Low awareness regarding this drug
- 3.1.3. Market Opportunities
- 3.1.3.1. Increasing research and development in the drugs
Chapter 4. Global Menopause Drug Market Industry Analysis
- 4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model (2019-2028)
- 4.2. PEST Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.3. Investment Adoption Model
- 4.4. Analyst Recommendation & Conclusion
- 4.5. Top investment opportunity
- 4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
- 5.1.1. Assessment of the overall impact of COVID-19 on the industry
- 5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Menopause Drug Market, by Stages Type
- 6.1. Market Snapshot
- 6.2. Global Menopause Drug Market by Stages Type, Performance - Potential Analysis
- 6.3. Global Menopause Drug Market Estimates & Forecasts by Stages Type 2019-2028 (USD Billion)
- 6.4. Menopause Drug Market, Sub Segment Analysis
- 6.4.1. Perimenopause
- 6.4.2. Menopause
- 6.4.3. Post menopause
Chapter 7. Global Menopause Drug Market, by Treatment Type
- 7.1. Market Snapshot
- 7.2. Global Menopause Drug Market by Treatment Type, Performance - Potential Analysis
- 7.3. Global Menopause Drug Market Estimates & Forecasts by Treatment Type 2019-2028 (USD Billion)
- 7.4. Menopause Drug Market, Sub Segment Analysis
- 7.4.1. Non-Hormonal Treatment
- 7.4.2. Hormonal Treatment
- 7.4.3. Herbal Supplements
Chapter 8. Global Menopause Drug Market, by Product Type
- 8.1. Market Snapshot
- 8.2. Global Menopause Drug Market by Product Type, Performance - Potential Analysis
- 8.3. Global Menopause Drug Market Estimates & Forecasts by Product Type 2019-2028 (USD Billion)
- 8.4. Menopause Drug Market, Sub Segment Analysis
- 8.4.1. Patch
- 8.4.2. Pill
- 8.4.3. Gel
- 8.4.4. Injectable
- 8.4.5. Cream
- 8.4.6. Others
Chapter 9. Global Menopause Drug Market, by Route of Administration Type
- 9.1. Market Snapshot
- 9.2. Global Menopause Drug Market by Route of Administration Type, Performance - Potential Analysis
- 9.3. Global Menopause Drug Market Estimates & Forecasts by Route of Administration Type 2019-2028 (USD Billion)
- 9.4. Menopause Drug Market, Sub Segment Analysis
- 9.4.1. Oral
- 9.4.2. Injectable
- 9.4.3. Topical
Chapter 10. Global Menopause Drug Market, by End Users
- 10.1. Market Snapshot
- 10.2. Global Menopause Drug Market by End Users, Performance - Potential Analysis
- 10.3. Global Menopause Drug Market Estimates & Forecasts by End Users 2019-2028 (USD Billion)
- 10.4. Menopause Drug Market, Sub Segment Analysis
- 10.4.1. Hospitals
- 10.4.2. Homecare
- 10.4.3. Specialty Clinics
- 10.4.4. Others
Chapter 11. Global Menopause Drug Market, Regional Analysis
- 11.1. Menopause Drug Market, Regional Market Snapshot
- 11.2. North America Menopause Drug Market
- 11.2.1. U.S. Menopause Drug Market
- 11.2.1.1. Stages Type breakdown estimates & forecasts, 2019-2028
- 11.2.1.2. Treatment Type breakdown estimates & forecasts, 2019-2028
- 11.2.1.3. Product Type breakdown estimates & forecasts, 2019-2028
- 11.2.1.4. Route of Administration Type breakdown estimates & forecasts, 2019-2028
- 11.2.1.5. End Users breakdown estimates & forecasts, 2019-2028
- 11.2.2. Canada Menopause Drug Market
- 11.3. Europe Menopause Drug Market Snapshot
- 11.3.1. U.K. Menopause Drug Market
- 11.3.2. Germany Menopause Drug Market
- 11.3.3. France Menopause Drug Market
- 11.3.4. Spain Menopause Drug Market
- 11.3.5. Italy Menopause Drug Market
- 11.3.6. Rest of Europe Menopause Drug Market
- 11.4. Asia-Pacific Menopause Drug Market Snapshot
- 11.4.1. China Menopause Drug Market
- 11.4.2. India Menopause Drug Market
- 11.4.3. Japan Menopause Drug Market
- 11.4.4. Australia Menopause Drug Market
- 11.4.5. South Korea Menopause Drug Market
- 11.4.6. Rest of Asia Pacific Menopause Drug Market
- 11.5. Latin America Menopause Drug Market Snapshot
- 11.5.1. Brazil Menopause Drug Market
- 11.5.2. Mexico Menopause Drug Market
- 11.6. Rest of The World Menopause Drug Market
Chapter 12. Competitive Intelligence
- 12.1. Top Market Strategies
- 12.2. Company Profiles
- 12.2.1. Teva Pharmaceutical Industries Ltd.
- 12.2.1.1. Key Information
- 12.2.1.2. Overview
- 12.2.1.3. Financial (Subject to Data Availability)
- 12.2.1.4. Product Summary
- 12.2.1.5. Recent Developments
- 12.2.2. Teva Pharmaceutical Industries Ltd.
- 12.2.3. Eli Lilly and Company
- 12.2.4. Cipla Inc
- 12.2.5. Allergan
- 12.2.6. Pfizer, Inc
- 12.2.7. Novo Nordisk A/S
- 12.2.8. Novartis AG
- 12.2.9. Merck & Co., Inc
- 12.2.10. Emcure
- 12.2.11. Viramal,
- 12.2.12. EuroPharma USA
Chapter 13. Research Process
- 13.1. Research Process
- 13.1.1. Data Mining
- 13.1.2. Analysis
- 13.1.3. Market Estimation
- 13.1.4. Validation
- 13.1.5. Publishing
- 13.2. Research Attributes
- 13.3. Research Assumption